Endovascular treatment of the subclavian artery pseudoaneurysm: Two case reports

Endovascular treatment is widely used for treating the subclavian artery pseudoaneurysm (SAP) because of its small trauma, fast recovery, exact effect, and low incidence of complications. However, when the systemic disease or infection that causes SAP is in the active phase, treatment of the primary...

Full description

Bibliographic Details
Main Authors: Hao Cai, Yunfeng Pang, Ziqiang Sun, Song Jin
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Vascular Investigation and Therapy
Subjects:
Online Access:http://www.vitonline.org/article.asp?issn=2589-9686;year=2023;volume=6;issue=1;spage=20;epage=24;aulast=Cai
Description
Summary:Endovascular treatment is widely used for treating the subclavian artery pseudoaneurysm (SAP) because of its small trauma, fast recovery, exact effect, and low incidence of complications. However, when the systemic disease or infection that causes SAP is in the active phase, treatment of the primary disease is more critical. Surgical intervention should be performed after systemic symptoms have been controlled unless the situation is particularly critical. We introduced two cases of SAP caused by brucellosis and Behcet's disease and discussed the course of treatment.
ISSN:2589-9686
2589-9481